Beginner
- Dose
- 300 mcg (0,3 mg) por dia Original in PT-BR
- Frequency
- Diária Original in PT-BR
- Duration
- Semanas 1–2 Original in PT-BR
- Notes
- Tabela de planejamento do site; 9 unidades com frasco de 10 mg + 3 mL de água bacteriostática. Original in PT-BR
KNOWLEDGE · COMPOUNDS
Adamax
Also known as: Adamax nasal
CognitiveEarly research
Overview
Written by EagleThis description was written by Eagle in each of the three languages. It is not imported text and carries no translation warning. What it says comes from the compound’s own composition, its pharmacological class and what the library records — no efficacy claim, and no Eagle recommendation of use.
Referência de pesquisa comunitária; o site não apresenta estudo de rota específica nem meia-vida estabelecida.
Adamax is catalogued under Cognitive. 0 Eagle articles in this library reference this compound.
- Category
- Cognitive
- Research stage
- Early research — Pesquisa inicial Original in PT-BR
- Eagle articles on this compound
- 0 Eagle articles
Mechanism
O site descreve Adamax como um composto de pesquisa com uso intranasal ou subcutâneo. Original in PT-BR
Chemical information
- CAS
- Not recorded in the source.
- Molecular formula
- Not recorded in the source.
- Molecular weight
- Not recorded in the source.
- Sequence
- Not recorded in the source.
- Amino acids
- Not recorded in the source.
- Solubility
- Not recorded in the source.
- Stability
- Not recorded in the source.
- Half-life
- Not recorded in the source.
- Bioavailability
- Not recorded in the source.
- Onset
- Not recorded in the source.
- Routes
- Intranasal · Subcutânea
Research references
No individual dosing recommendation is given. Values are as recorded in the source, with species and route stated where known.
No research references recorded in the source.
Safety
No safety information recorded in the source.
Reported protocols
Recorded in the imported source as community protocols. They are NOT Eagle protocols, were not reviewed by Eagle, and are not a dosing recommendation, a prescription or clinical guidance. Values appear exactly as recorded, in the language they were written in.
Intermediate
- Dose
- 500–750 mcg (0,5–0,75 mg) por dia Original in PT-BR
- Frequency
- Diária Original in PT-BR
- Duration
- Semanas 3–6 Original in PT-BR
- Notes
- Semanas 3–4: 500 mcg; semanas 5–6: 750 mcg. Original in PT-BR
Advanced
- Dose
- 1.000 mcg (1 mg) por dia Original in PT-BR
- Frequency
- Diária Original in PT-BR
- Duration
- Semanas 7–8 Original in PT-BR
- Notes
- 30 unidades no exemplo de 10 mg + 3 mL; sem conversão validada entre vias. Original in PT-BR
Vial sizes: 10 mg — Peptide Calculator
Interactions
No relations recorded in the source.
Related
No Eagle article in this library references this compound yet.